Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 5—May 2012
Dispatch

Human Infections with Novel Reassortant Influenza A(H3N2)v Viruses, United States, 2011

Stephen Lindstrom, Rebecca Garten, Amanda Balish, Bo Shu, Shannon Emery, LaShondra Berman, Nathelia Barnes, Katrina Sleeman, Larisa Gubareva, Julie Villanueva, and Alexander KlimovComments to Author 
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Lindstrom, R. Garten, A. Balish, B. Shu, S. Emery, L. Berman, K. Sleeman, L. Gubareva, J. Villanueva, A. Klimov); Battelle, Atlanta (N. Barnes)

Main Article

Figure 2

Phylogenetic analysis of the A) hemagglutinin and B) matrix genes of influenza A(H3N2)v viruses. Sequences obtained from human A(H3N2)v isolates in the United States during 2011 are shown in boldface; sequences of proposed vaccine virus are underlined. Scale bars indicate number of base substitutions per site.

Figure 2. . Phylogenetic analysis of the A) hemagglutinin and B) matrix genes of influenza A(H3N2)v viruses. Sequences obtained from human A(H3N2)v isolates in the United States during 2011 are shown in boldface; sequences of proposed vaccine virus are underlined. Scale bars indicate number of base substitutions per site.

Main Article

Page created: April 17, 2012
Page updated: April 17, 2012
Page reviewed: April 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external